Exhibit 192 · Research article
Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation
No cases of invasive cancer were recorded in women immunized at 12 or 13 years of age irrespective of the number of doses.
Population-based study of Scottish women born 1988 to 1996. No cases of invasive cervical cancer occurred among women immunized at ages 12 to 13, regardless of the number of doses. Women vaccinated at 14 to 22 with three doses had 3.2 cases per 100,000 against 8.4 per 100,000 in unvaccinated women. The vaccine was bivalent.
- Source
- Palmer et al., Journal of the National Cancer Institute 116: 857–865
- Date
- 22 January 2024
- Quoted from
- Abstract, Results
- Grade
- Peer-reviewed
- Document
- https://doi.org/10.1093/jnci/djad263
- Accessed
- 2026-11-09
- Cited by
- Findings citing this exhibit